These hybrids (for example, 47–50; Figure 15) showed stronger anti-tumor activity by inhibiting the biosynthesis of NAD+, exhibiting stronger tumor-suppressing activity and promoting T cell proliferation by inhibiting IDO activity. This evidence concerns the gene IDO1 and neoplasm.